Aliena-Valero, Alicia
Rius-Pérez, Sergio
Baixauli-Martín, Júlia
Torregrosa, Germán
Chamorro, Ángel
Pérez, Salvador http://orcid.org/0000-0003-0766-1744
Salom, Juan B. http://orcid.org/0000-0002-4162-6101
Funding for this research was provided by:
Instituto de Salud Carlos III (RD16/0019/0008)
Article History
Received: 29 February 2020
Accepted: 2 September 2020
First Online: 22 September 2020
Compliance with Ethical Standards
:
: The funding source had no further role in study design; in the collection, analysis, and interpretation of data; in the writing the report; and in the decision to submit the paper for publication.
: Ángel Chamorro is inventor of the patent “Pharmaceutical composition for neuroprotective treatment in patients with ictus comprising citicoline and uric acid” and whose proprietor is Hospital Clinic of Barcelona, Spain. The other authors declare no competing interests.
: Experiments were conducted in compliance with the legislation on protection of animals used for scientific purposes in Spain (RD 53/2013) and the EU (Directive 2010/63/EU). Protocols were approved by the Animal Experimentation Ethics Committee from IIS La Fe.